130 related articles for article (PubMed ID: 34393429)
1. Molecular docking analysis of pyruvate kinase M2 with a potential inhibitor from the ZINC database.
Sharma P; Singh M; Sharma S
Bioinformation; 2021; 17(1):139-146. PubMed ID: 34393429
[TBL] [Abstract][Full Text] [Related]
2. Detection of Nail Oncometabolite SAICAR in Oral Cancer Patients and Its Molecular Interactions with PKM2 Enzyme.
Patel R; Raj AK; Lokhande KB; Almasri MA; Alzahrani KJ; Almeslet AS; Swamy KV; Sarode GS; Sarode SC; Patil S; Sharma NK
Int J Environ Res Public Health; 2021 Oct; 18(21):. PubMed ID: 34769743
[TBL] [Abstract][Full Text] [Related]
3. Identification of a new pyruvate kinase M2 isoform (PKM2) activator for the treatment of non-small-cell lung cancer (NSCLC).
Li RZ; Fan XX; Shi DF; Zhu GY; Wang YW; Luo LX; Pan HD; Yao XJ; Leung EL; Liu L
Chem Biol Drug Des; 2018 Nov; 92(5):1851-1858. PubMed ID: 29931766
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel naphthoquinone derivatives as inhibitors of the tumor cell specific M2 isoform of pyruvate kinase.
Ning X; Qi H; Li R; Li Y; Jin Y; McNutt MA; Liu J; Yin Y
Eur J Med Chem; 2017 Sep; 138():343-352. PubMed ID: 28688274
[TBL] [Abstract][Full Text] [Related]
5. Discovery and structure-guided fragment-linking of 4-(2,3-dichlorobenzoyl)-1-methyl-pyrrole-2-carboxamide as a pyruvate kinase M2 activator.
Matsui Y; Yasumatsu I; Asahi T; Kitamura T; Kanai K; Ubukata O; Hayasaka H; Takaishi S; Hanzawa H; Katakura S
Bioorg Med Chem; 2017 Jul; 25(13):3540-3546. PubMed ID: 28511909
[TBL] [Abstract][Full Text] [Related]
6. Discovery of 3-(trifluoromethyl)-1H-pyrazole-5-carboxamide activators of the M2 isoform of pyruvate kinase (PKM2).
Xu Y; Liu XH; Saunders M; Pearce S; Foulks JM; Parnell KM; Clifford A; Nix RN; Bullough J; Hendrickson TF; Wright K; McCullar MV; Kanner SB; Ho KK
Bioorg Med Chem Lett; 2014 Jan; 24(2):515-9. PubMed ID: 24374270
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumor activity of novel 2, 3-didithiocarbamate substituted naphthoquinones as inhibitors of pyruvate kinase M2 isoform.
Ning X; Qi H; Li R; Jin Y; McNutt MA; Yin Y
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):126-129. PubMed ID: 29185365
[TBL] [Abstract][Full Text] [Related]
8. Discovery and structure-activity relationship of novel 4-hydroxy-thiazolidine-2-thione derivatives as tumor cell specific pyruvate kinase M2 activators.
Li R; Ning X; Zhou S; Lin Z; Wu X; Chen H; Bai X; Wang X; Ge Z; Li R; Yin Y
Eur J Med Chem; 2018 Jan; 143():48-65. PubMed ID: 29172082
[TBL] [Abstract][Full Text] [Related]
9. Succinyl-5-aminoimidazole-4-carboxamide-1-ribose 5'-Phosphate (SAICAR) Activates Pyruvate Kinase Isoform M2 (PKM2) in Its Dimeric Form.
Yan M; Chakravarthy S; Tokuda JM; Pollack L; Bowman GD; Lee YS
Biochemistry; 2016 Aug; 55(33):4731-6. PubMed ID: 27481063
[TBL] [Abstract][Full Text] [Related]
10. New pyridin-3-ylmethyl carbamodithioic esters activate pyruvate kinase M2 and potential anticancer lead compounds.
Zhang Y; Liu B; Wu X; Li R; Ning X; Liu Y; Liu Z; Ge Z; Li R; Yin Y
Bioorg Med Chem; 2015 Aug; 23(15):4815-4823. PubMed ID: 26081759
[TBL] [Abstract][Full Text] [Related]
11. Pyruvate Kinase M2 and Cancer: The Role of PKM2 in Promoting Tumorigenesis.
Zahra K; Dey T; Ashish ; Mishra SP; Pandey U
Front Oncol; 2020; 10():159. PubMed ID: 32195169
[TBL] [Abstract][Full Text] [Related]
12. Pyruvate kinase M2 at a glance.
Yang W; Lu Z
J Cell Sci; 2015 May; 128(9):1655-60. PubMed ID: 25770102
[TBL] [Abstract][Full Text] [Related]
13. Pantoprazole inhibits human gastric adenocarcinoma SGC-7901 cells by downregulating the expression of pyruvate kinase M2.
Shen Y; Chen M; Huang S; Zou X
Oncol Lett; 2016 Jan; 11(1):717-722. PubMed ID: 26870273
[TBL] [Abstract][Full Text] [Related]
14. Tumor pyruvate kinase M2: A promising molecular target of gastrointestinal cancer.
Guo C; Li G; Hou J; Deng X; Ao S; Li Z; Lyu G
Chin J Cancer Res; 2018 Dec; 30(6):669-676. PubMed ID: 30700935
[TBL] [Abstract][Full Text] [Related]
15. Posttranslational Modifications of Pyruvate Kinase M2: Tweaks that Benefit Cancer.
Prakasam G; Iqbal MA; Bamezai RNK; Mazurek S
Front Oncol; 2018; 8():22. PubMed ID: 29468140
[TBL] [Abstract][Full Text] [Related]
16. Isoform switch of pyruvate kinase M1 indeed occurs but not to pyruvate kinase M2 in human tumorigenesis.
Zhan C; Yan L; Wang L; Ma J; Jiang W; Zhang Y; Shi Y; Wang Q
PLoS One; 2015; 10(3):e0118663. PubMed ID: 25738776
[TBL] [Abstract][Full Text] [Related]
17. Pyruvate kinase M2 affects liver cancer cell behavior through up-regulation of HIF-1α and Bcl-xL in culture.
Dong T; Yan Y; Chai H; Chen S; Xiong X; Sun D; Yu Y; Deng L; Cheng F
Biomed Pharmacother; 2015 Feb; 69():277-84. PubMed ID: 25661370
[TBL] [Abstract][Full Text] [Related]
18. Integrated In Silico-In Vitro Discovery of Lung Cancer-related Tumor Pyruvate Kinase M2 (PKM2) Inhibitors.
Ye X; Sun Y; Xu Y; Chen Z; Lu S
Med Chem; 2016; 12(7):613-620. PubMed ID: 26951145
[TBL] [Abstract][Full Text] [Related]
19. 1-(sulfonyl)-5-(arylsulfonyl)indoline as activators of the tumor cell specific M2 isoform of pyruvate kinase.
Yacovan A; Ozeri R; Kehat T; Mirilashvili S; Sherman D; Aizikovich A; Shitrit A; Ben-Zeev E; Schutz N; Bohana-Kashtan O; Konson A; Behar V; Becker OM
Bioorg Med Chem Lett; 2012 Oct; 22(20):6460-8. PubMed ID: 22963766
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of the M2 Isoform of Pyruvate Kinase (PKM2) with shRNA Enhances the Effect of Docetaxel in Human NSCLC Cell Lines In Vitro.
Yuan S; Qiao T; Zhuang X; Chen W; Xing N; Zhang Q
Yonsei Med J; 2016 Nov; 57(6):1312-23. PubMed ID: 27593857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]